Lamberto Andreotti
CIK 1208099 · Chief Executive Officer · last filed 2025-05-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BMY price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
345 PARK AVENUE
NEW YORK, NY 10154
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTVA | Director | 37,784 | $12.54 | $474.0K | -$2.6K | 8 | 2025-05-02 |
| DD | Director | 17,711 | $135.64 | $2.40M | $8.6K | 27 | 2019-06-26 |
| DuPont de Nemours, Inc. (DWDP) Delisted | Director | 21,655 | — | — | $0 | 7 | 2018-09-18 |
| BMY | Director | 1,152,571 | $61.53 | $70.92M | -$101.58M | 87 | 2017-04-10 |
| Mead Johnson Nutrition Co (MJN) Delisted | Director | 19,609 | — | — | $144.0K | 2 | 2009-12-28 |
Recent Filings · Page 5 of 14
131 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-05-04 | BMY | Mixed | — | -$10.76M | EDGAR |
| 2016-04-29 | DD | Grant (A) | +2,230 | $0 | EDGAR |
| 2016-04-06 | BMY | Sell (S) | −23,200 | -$1.53M | EDGAR |
| 2016-03-16 | DD | Grant (A) | +58 | $3.7K | EDGAR |
| 2016-03-14 | BMY | Mixed | +90,340 | -$7.41M | EDGAR |
| 2016-03-10 | BMY | Sell (S) | −23,200 | -$1.52M | EDGAR |
| 2016-02-16 | BMY | Sell (S) | −23,200 | -$1.38M | EDGAR |
| 2016-02-08 | BMY | Mixed | +105,630 | -$7.65M | EDGAR |
| 2016-02-03 | BMY | Grant (A) | — | $0 | EDGAR |
| 2016-01-06 | BMY | Sell (S) | −23,200 | -$1.57M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.